Large Cap
Medical Devices
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Abbott
ABT
$180B
| $180B | $103.06 | 2.29% |
|
| 2 |
2
Stryker
SYK
$127B
| $127B | $330.25 | 3.54% |
|
| 3 |
3
Medtronic
MDT
$107B
| $107B | $83.21 | 1.46% |
|
| 4 |
4
Boston Scientific
BSX
$65.8B
| $65.8B | $44.25 | 1.54% |
|
| 5 |
5
Edwards Lifesciences
EW
$47.6B
| $47.6B | $82.63 | 1.42% |
|
| 6 |
6
DexCom
DXCM
$27.6B
| $27.6B | $71.54 | 1.5% |
|
| 7 |
7
GE HealthCare
GEHC
$27.6B
| $27.6B | $60.58 | 2.27% |
|
| 8 |
8
Philips
PHG
$25.4B
| $25.4B | $26.17 | 0.54% |
|
| 9 |
9
Steris
STE
$20.9B
| $20.9B | $214.07 | 1.63% |
|
| 10 |
10
Zimmer Biomet
ZBH
$17.7B
| $17.7B | $91.35 | 1.9% |
|
| 11 |
11
Smith & Nephew
SNN
$12.9B
| $12.9B | $30.57 | 2.69% |
|
| 12 |
12
Penumbra
PEN
$12.5B
| $12.5B | $318.73 | 0.26% |
|
| 13 |
13
Insulet
PODD
$11.3B
| $11.3B | $163.26 | 3.08% |
|
| 14 |
14
Globus Medical
GMED
$10.4B
| $10.4B | $76.49 | 1.42% |
|
Large Cap Medical Devices Stocks at a Glance
Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.
There are 14 large cap Medical Devices stocks — companies in the Medical Devices industry with a market cap between $10B and $200B — worth a combined $692B.
The largest by market cap are Abbott (ABT) at $180B, Stryker (SYK) at $127B and Medtronic (MDT) at $107B.
Among institutional investors, DexCom (DXCM) drew the most net new fund positions in Q1 2026: 149 funds opened new positions, taking total fund holders up 36 (3.9%) quarter-over-quarter.
- Combined market cap: $692B across 14 stocks.
- Large Cap: market cap between $10B and $200B.
- Largest constituent: Abbott (ABT), $180B market cap.
- Most net new fund positions in Q1 2026: DexCom (DXCM), +36 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.